☆ 4.6 Letter

Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia

JOURNAL OF CLINICAL IMMUNOLOGY (2016)

Journal

JOURNAL OF CLINICAL IMMUNOLOGY

Volume 36, Issue 5, Pages 434-436

Publisher

SPRINGER/PLENUM PUBLISHERS

DOI: 10.1007/s10875-016-0282-5

Keywords

-

Categories

Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.